SCHEMBL22818089

SCHEMBL22818089

c1ccc(-c2ccc(N(c3cccc(-c4ccccc4)c3)c3cc4c(oc5cccc(-c6cccc(-c7ccccc7)c6)c54)c4ccccc34)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.38
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ PRKDC P78527 3/20 0.32
▸ PLA2G10 O15496 1/20 0.32
▸ GGPS1 O95749 1/20 0.32
▸ PIM1 P11309 1/20 0.31
▸ CSNK2A2 P19784 1/20 0.31
▸ CSNK2B P67870 1/20 0.31
▸ PIM3 Q86V86 1/20 0.31
▸ PIM2 Q9P1W9 1/20 0.31
▸ MAPT P10636 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ PTGES2 Q9H7Z7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22818455 1.00 ALOX5 (0.38) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22818475 1.00 ALOX5 (0.38) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22818416 0.99 ALOX5 (0.39) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22818415 0.98 ALOX5 (0.40) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22817941 0.98 ALOX5 (0.40) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22817940 0.98 ALOX5 (0.37) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22818162 0.97 ALOX5 (0.39) ALOX5PRKDCGGPS1PTGES2
SCHEMBL22817947 0.97 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APLA2G10GGPS1
SCHEMBL22818454 0.96 ALOX5 (0.40) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22818105 0.96 ALOX5 (0.40) ALOX5PLA2G2APLA2G4APRKDCPLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885PLA2G2A 4271/4885PLA2G4A 3979/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885PLA2G2A 4271/4885PLA2G4A 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback